EMD-25167

Single-particle
6.4 Å
EMD-25167
3D View Gallery
Deposition: 19/10/2021
Map released: 04/05/2022
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-25167
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

Antibody 11-11 in complex with prefusion SARS-CoV-2 B.1.351 Spike glycoprotein

EMD-25167

Single-particle
6.4 Å
EMD-25167
3D View Gallery
Deposition: 19/10/2021
Map released: 04/05/2022
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: Antibody 11-11 in complex with prefusion SARS-CoV-2 B.1.351 Spike glycoprotein

Deposition Authors: Casner RG , Shapiro L
An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses.
Liu L , Iketani S , Guo Y , Reddem ER , Casner RG , Nair MS , Yu J, Chan JF , Wang M, Cerutti G , Li Z, Morano NC , Castagna CD , Corredor L , Chu H , Yuan S , Poon VK , Chan CC , Chen Z , Luo Y , Cunningham M , Chavez A, Yin MT , Perlin DS , Tsuji M , Yuen KY , Kwong PD , Sheng Z , Huang Y , Shapiro L , Ho DD
(2022) Sci Transl Med , 14 , eabn6859 - eabn6859
PUBMED: 35438546
DOI: doi:10.1126/scitranslmed.abn6859
ISSN: 1946-6242
Grant Support: